JUL 28, 2026 · JOURNAL ARTICLE
Prime-Target neoantigen vaccination strategy enhances neoantigen-specific T cell immunity at the tumor microenvironment in murine cold tumor models 2256928
The Journal of Immunology
A sound preclinical study in murine cold tumor models showing mechanistic evidence of enhanced neoantigen-specific T cell immunity and tumor control, but limited to in vivo animal work without human clinical data.
Study details
DesignPreclinical controlled in vivo study in mur…
InterventionPrime-Target neoantigen vaccination: subcut…
ComparatorControl groups receiving intra-tumor adjuva…